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International Trade Agreements:
Vehicle for Better Public Health?
Jason Sapsin,Ann MarieKimball, and DavidFidler(Moderator)

Jason Sapsin
The United States is behind the curve in thinking
about trade and public health. Looking into the
future, trade and public health are two of the most
important topics of discussion.
This is the tenth anniversary of the World Trade
Organization (WTO). The WTO, which is based in
Switzerland, is not a United Nations (UN) agency. It
has 148 members and 630 staff, and its Director
General is Supachai Panitchpaki of Thailand. The
WTO represents a formal break with the UN and the
WTO establishes trade agreements, develops policies,
and encourages cooperation with other agencies.
Among the health-related agreements promulgated
by the WTO are the General Agreement on Tariffs and
Trade (GATT) which was signed in 1947; the General
Agreement on Trade in Services (GATS) which was
signed in 1995; the agreement on Trade-Related
Aspects of Intellectual Property Rights (TRIPs) which
was signed in 1994; the Agreement on Sanitary and
Phytosanitary Measures (SPS) which took effect in
1995; and the Technical Barriers to Trade (TBT)
which took effect in 1996.
In regard to trade and health, the universal economic argument is that more trade leads to more
wealth, which leads to better health. These can be
called the general effects of trade on health, but it is
not always clear that this is the way it always happens.
It is hard to evaluate simple policy statements on the
effects of trade on health. The United States currently
believes that trade can do more to boost a developing
country's economy than directing aid and resources to
that country.
The specific effects of trade on health include
changes in the product mix, changes in the services
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and providers mix, and changes in willingness to regulate. Products appear where they did not before and
new services and providers, which make up 20% of
world trade, appear. It should be noted that lawyers
are not big on economic theory, but we do understand
pesticide regulation, health care issues, and other
areas where law affects health. While willingness to
regulate has benefits, it can also affect trade negatively.
A common thread is the ability of the WTO to stress
participation of markets in member nations. Trade
tends to look at public health as inherently limiting
market access. The WTO would like to make market
access much easier.
In regard to product availability, issues arise when
a product, such as alcohol or asbestos, is taxed differently from other products or when a product such as
firearms is introduced into a market. When a country
seeks access to the WTO, members of the WTO can
apply pressure to that country to change its trade
policies.
Another area where product availability becomes
an issue is food and diet. Reports have stated that
changes in behavior when new foods are introduced
into a market can result in detrimental health choices.
While some would say there are no bad foods, fatty
and sugary foods are becoming the next tobacco.
Issues over food show the tension between trade,
commerce, and public health.
With services and providers, this movement can be
seen in health providers and in who controls access to
water. An example of the change in willingness to regulate can be seen in the example of Methanex, an
additive in gas. California found the additive to be
harmful to the environment, but because of the North
American Free Trade Agreement (NAFTA), the dis-
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pute became an issue of investor protection instead of
public health.
Trade represents the free market approach to reducing poverty and those in favor of this approach argue
that we need privatization of markets. This can be
seen in the percentages of net capital now moving
between countries, where 82% of trade is between private parties and 9% is between public entities.
Privatization is fueled by globalization, international financial institutions, and a push to overcome corruption and inefficiency. Privatization may be a cause
for concern, because the private sector may clash over
public priorities. For example, if the population is
poor, then investors may not be motivated to enter the
market. Privatization may also lead to loss of local
development.
Water privatization is a good example of what we
know about privatization of previously publicly controlled services. In privatization, the focus is on labor
productivity, firm growth, and market valuation, but
not on public health. This does not produce a good
picture of how these efforts play out over time.
Physical access may be improved in poor areas, but
such access is estimated indirectly. Water piracy may
prevent these numbers from reflecting reality. In
addition, non-privatized areas usually already have
fairly high rates of access to water, so starting where
there is no access to water will allow providers to show
statistics of success much more easily. Studies have
also shown that child mortality has declined in areas
where water access is privatized, but over the long
term, the public entities offer comparable services and
child mortality rates even out.
Trade can disrupt public health practices and influence shifts in public health, especially in the transfer
of food. In addition, the commoditization of goods
does not "feel good.' It feels disturbing to put control
of water access in private hands. Barriers to increased
awareness to the effects of trade on public health are
institutional resistance, lack of resources and coordination, and lack of balanced advocacy.
The World Health Organization (WHO) recommends training, compliance counseling for SBT and
TBT, more interaction between public health and
trade, and health impact assessments. It should be
noted that, in their recent report on the future of the
WTO, the WTO did not mention the WHO, whose
offices are just down the street from the WTO. It is not
enough to say trade is a problem for public health.
The WHO thinks trade is a problem, but we cannot
ignore trade. Trade is not going away. How it affects
public health will depend on the participation of public health officials in the debate.

Ann MarieKimball
Public health's core mission is to protect populations
from infectious diseases. However, despite the enormous range of global trade, there is no working group
on health at the World Trade Organization (WTO). It
should be noted that trade is good for some regions,
especially the Asian Pacific region, where even nonmarket economies such as China and Vietnam have
seen positive results from trade. Therefore, when discussing the effects of trade on public health, we need
to specify the effects region by region.
The world population has reached unprecedented
levels, but the world urban population is mostly centered in developing countries. Access to water and
sanitation in those areas is uneven, with about 1 billion people short on water and 2 billion people short
on sanitation.
Uncontrolled urbanization plus globalization of
travel and trade can equal huge risks. This can be seen
in the agricultural poultry industry. Pathogenic
influenza led to the deaths of millions of chickens and,
as a result, millions of dollars. The intensification of
poultry agriculture in poor sanitary environments can
lead to high risks because disease in those areas is difficult to control. In a pandemic, the primary level of
microbial traffic is at the point of emergence. The secondary level is by local extension, and the tertiary
level is in geographically dispersed clusters.
Trade-related infections emerge coincidently with
ramping up production for global market demands,
increased efficiencies mandated by tariffs, or innovations in product manufacturing. Reducing tariffs
increases market access and increases competition. In
the case of HIV/AIDS, transmission was amplified
through global trade. In addition, a description of
infection can cause disruption in travel and trade,
which can be extremely expensive.
Poultry exports from East Asia increased 25 fold in
the decade preceding 2000. This was a result of a
need for high-protein food, and much of the poultry
was eaten fresh in the region. Now there is a need to
restructure the poultry industry, but we do not have
the metrics to measure successful restructuring.
There is now active surveillance in place for avian
influenza. While there is a high human mortality rate
for avian influenza, the disease does not transfer from
human to human very well. The threshold of this pandemic is not yet known. However, even in the best situation, the risks associated with avian influenza are
high.
Other examples of diseases being transmitted as a
result of ramping up, consolidation, advances in pro-
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cessing, and pooling of biological materials in processing include HIV/AIDS in the Factor VII global
market, E. coli 0157:H7 in beef, and bovine spongiform encephalitis (BSE or "mad cow"), in beef. BSE
transmission may have been related to changes in rendering and increased efficiencies that were needed as
a result of GATT pressure on beef tariffs.
Among the "tools of the trade" are agreements such
as the General Agreement on Tariffs and Trade
(GATT), the Technical Barriers to Trade (TBT), and
the Agreement on Sanitary and Phytosanitary
Measures (SPS), which have interactions with emergence paradigms. The GATT's commitment to tariff
reduction may lead to enhanced efficiency. In addition, both TBT and SPS mandate notification of
urgent trade restrictions, and human health concerns
are the leading rationale for notification in both cases.
In the case of BSE, notification practically stopped
beef export from Great Britain. The notification may
be a smokescreen, though, given the high number of
notifications each year. Also, the World Health
Organization (WHO) is not given access to the information in the notifications.
Can public health pull the brakes on the global
express? Local systems for isolation, quarantine, and
epidemiological investigation and control are weak.
Other options are recall of products and trade restrictions, but these are in doubt. While the WTO already
has a committee on the environment, the WTO also
needs a committee on health. Remedies for microbial
traffic can start with national and local public health
agencies and then move to the WHO and WTO.
In the new International Health Regulations (IHR),
which create a positive obligation to create capacity
within countries and a mechanism for declaring public health emergencies, there is no mention of trade or
contact with the WTO. The regulations, which will be
implemented in 2007, will seek to enfranchise poor
countries to establish public health infrastructures.
The future of world trade still raises questions. Will
the mandates for "safety nets" in countries in the IHR
be realized? Can these measures mitigate risks? Will
product alerts through urgent measures reach the
WHO in a timely manner? Can the WTO and WHO
work together on secondary prevention? Currently,
there is little operational discussion between the two
parties. Finally, will it take a pandemic to get a standing committee on health at the WTO? Eventually,
both sides, trade and public health, must come
together.

David P. Fidler
Over the past ten years, the World Trade Organization
(WTO) dominated the relationship between public
health and international trade. But what does the next
decade portend? Analyzing this question involves
looking at three areas: (1) potential developments
within the WTO; (2) the proliferation of bilateral and
regional trade agreements; and (3) the implementation of the new International Health Regulations
(IHR).
Potentialdevelopments within the WTO. In the next
decade, the trade-health relationship is intertwined
with the fate of the Doha Development Agenda, the
failure of which may mean that poverty and its attendant public health problems will become even more
entrenched. Thus, the Doha Development Agenda
itself is important from a public health perspective.
In terms of specific WTO agreements, potential
developments with the agreement on Trade-Related
Aspects of Intellectual Property Rights (TRIPs), the
Sanitary and Phytosanitary Measures (SPS) agreement, and the General Agreement on Trade in
Services (GATS) may have the most importance in the
next ten years. Concerning intellectual property, one
development to monitor is whether any countries take
advantage of the third-party compulsory licensing
mechanism established in 2003 (the so-called Agreement of the Implementation of Paragraph 6 of the
Doha Declaration). To date, no countries have utilized
this mechanism, even for anti-retrovirals. Another
area to watch is what impact the WHO Commission
on Intellectual Property Rights, Innovation, and Public Health will have on the controversies surrounding
intellectual property rights and public health.
Certain developments concerning the SPS Agreement might bear watching. In particular, the upcoming decision expected in the EC - Biotech, case, filed by
the U.S. against the EC's regulations on genetically
modified organisms, may be seminal for how the SPS
Agreement is interpreted and applied in the future.
Finally, the potential liberalization of trade in services under GATS is important. Negotiations on such
liberalization continue as part of the Doha Development Agenda, and how negotiations deal with healthrelated services will be critical. In addition, new case
law under GATS may also be forthcoming in the next
ten years. The recent decision in the US - Gambling2
case, although not involving public health, has implications for public health, especially with respect to
specific commitments on market access.
Proliferationof regional and bilateraltrade agreements. The "next wave" in the trade-public health
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relationship may be affected most by the proliferation
of regional and bilateral trade agreements. Instead of
a multilateral system, a complicated "spaghetti bowl"
of preferential trading arrangements is emerging. The
spaghetti bowl also includes approximately 2,000
bilateral investment treaties that regulate foreign
direct investment.
How does this spaghetti bowl of regional and bilateral agreements affect public health? So much attention has been focused on the WTO that, with some
exceptions, the public health community has been
slow to appreciate the proliferation of regional and
bilateral agreements represents. The impact on public
health of these regional and bilateral agreements
could be significant in each area of the trade-public
health relationship, including intellectual property
rights, SPS measures, services, and the manner in
which disputes are settled.
The Central American Free Trade Agreement
(CAFTA) provides an illustration. A number of public
health experts have argued that CAFTA represents a
threat to public health in the CAFTA nations (United
States, Costa Rica, Dominican Republic, El Salvador,
Guatemala, Honduras, and Nicaragua). Analytically,
assessment of the impact of agreements such as
CAFTA on public health could start by evaluating
their rules against relevant WTO agreements because
public health's familiarity with the WTO provides a
baseline for thinking about what's in the spaghetti
bowl.
Crudely, CAFTA2s rules on trade in goods, SPS
measures, technical barriers to trade, and general
exceptions for measures that protect human health
more or less track what's in WTO agreements. CAFTA
differs from WTO rules in three areas: protection of
intellectual property rights, trade in services, and dispute settlement. CAFTA contains provisions that
require greater protection of intellectual property
rights than TRIPS. In terms of services, CAFTA differs from GATS in that it applies market access and
national treatment obligations on CAFTA states parties, except for non-conforming measures the parties
list in an annex. This means that CAFTA's liberalization of trade in services is more aggressive than GATS.
Finally, CAFTA creates its own dispute settlement

mechanism that could be used instead of the WTO.
This creates another dispute settlement system public
health experts have to monitor for decisions that may
impact health policy.
This focus on CAFTA suggests that the implications
of regional and bilateral agreements are complex and
cannot be summarized by "sound bites'" The bottom
line is, however, that these regional and bilateral
agreements constitute an important topic on which
more public health attention is needed.
The new InternationalHealth Regulations (IHR).
The new IHR, adopted in May 2005, will affect the
trade-health relationship. The new IHR attempt to
balance trade and health interests as did the old IHR,
but the new IHR are radically different and more
demanding. What needs to be watched in the next
decade is whether the radical transformation the new
IHR represents is actually implemented in a way that
maximizes synergies between public health and trade.
The past decade was one in which public health had
to adjust to the WTO. The way in which the WTO
altered the relationship between trade and public
health had the ironic effect of making public health
more politically important than it had been in the
past. The next decade will be different as public health
will have to continue to deal with the WTO but also
swim in the spaghetti bowl of regional and bilateral
agreements. The new IHR adds another regime to the
mix in terms of the future relationship between trade
and public health.
The Holy Grail of this relationship has, of course,
been policy coherency between trade and public
health. Achieving such coherency will prove difficult;
and public health still does not have the muscle that
trade possesses, placing a greater burden on public
health to understand, influence, and manage international trade agreements in a way that shapes them, as
much as possible, into vehicles for better public
health.
1. Case C-6/99, Association Greenpeace France and Others v.
Ministere de lAgriculture et de la Peche and Others, 2000 E.C.R.
1-01651.
2. WTO First Panel Meeting in the Dispute between Antigua and
Barbuda and the United States on Internet Gambling, WT/DS
285 (Dec. 10, 2003), available at: http://www.antigua-barbuda.
com/business-politics/wto/wto index.asp.
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